Research article Deepak A Kaji, Andrew J Belli, Meredith C McCormack, Elizabeth C Matsui, D¿Ann L Williams, Laura Paulin, Nirupama Putcha, Roger D Peng, Gregory B Diette, Patrick N Breysse and Nadia N Hansel BMC Pulmonary Medicine 2014,...
Chronic obstructive pulmonary disease (COPD) is associated with eosinophilic airway inflammation in 10-20% of patients. Benralizumab, a monoclonal antibody, has been shown to decrease the number of blood and sputum eosinophils. In this trial of 101 patients with COPD...
Indian American physicians plan to hold a Global Healthcare Summit in Mumbai from Jan 2-4 to discuss ways to bring the most innovative, efficient and cost effective healthcare solutions for India. Organised by te Association of American Physicians of Indian Origin...
Munich, Germany, 8 September 2014 – Data from the pivotal phase III TONADO™ studies†,1 for tiotropium + olodaterol Respimat® FDC were presented for the first time today at the European Respiratory Society (ERS) International Congress 2014. The 52-week studies have...
Primary and Secondary Efficacy Endpoints Met for Doses 88 mcg and Above; TD-4208 Demonstrates Clear Dose-Response Relationship and FEV1 Profile Consistent with Once-Daily Dosing SOUTH SAN FRANCISCO, CA–(Marketwired – Sep 8, 2014) – Theravance...
RSS Error: A feed could not be found at `http://www.scoop.it/t/pulmonaryrehabnews/rss.xml`; the status code is `404` and content-type is `text/html;charset=UTF-8`
